SCHEMBL6981610

SCHEMBL6981610

COc1cc(N)cc(O)c1.COc1cc(N)cc(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 3/20 0.48
ABL1 P00519 2/20 0.47
ABCB1 P08183 2/20 0.47
BCR P11274 2/20 0.47
PTGS2 P35354 3/20 0.46
TTR P02766 2/20 0.46
CYP1A1 P04798 2/20 0.46
ALOX5 P09917 2/20 0.46
CYP1B1 Q16678 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
TP53 P04637 2/20 0.44
CALM1 P0DP23 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1794250 0.98 CYP3A4 (0.50) ALDH1A1CYP3A4ABL1ABCB1BCR
SCHEMBL233829 0.85 ALDH1A1 (0.69) ALDH1A1CYP3A4ABL1ABCB1BCR
SCHEMBL116606 0.85 ALDH1A1 (0.69) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL10988442 0.83 ALDH1A1 (0.65) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
SCHEMBL21611343 0.83 ALDH1A1 (0.65) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
SCHEMBL30365875 0.83 ALDH1A1 (0.65) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
Hydrochloric Acid SCHEMBL3275940 0.83 ALDH1A1 (0.65) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
Flamenol SCHEMBL69428 0.80 CYP3A4 (0.62) ALDH1A1CYP3A4ABL1ABCB1BCR
SCHEMBL5800828 0.80 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP1A1CYP1B1SMN1; SMN2
SCHEMBL6425437 0.78 F2 (0.45) ALDH1A1CYP3A4SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345914-A1 THERAPEUTIC COMPOUNDS AstraZeneca AB (SE) 2003-09-24 EP disclosed
WO-2002051821-A1 THERAPEUTIC COMPOUNDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed